BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Selling, general and administrative (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $2.6B | +7.0% | −0.6% | 1.4% |
| Selling, general and administrative (TTM) | $2.6B |
|---|---|
| YoY | +7.0% |
| 5-year CAGR | −0.6% |
| 10-year CAGR | 1.4% |
Selling, general and administrative
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $2.4B | +1.2% |
| 2024 | $2.4B | −5.7% |
| 2023 | $2.5B | +6.1% |
| 2022 | $2.4B | −10.1% |
| 2021 | $2.7B | +6.8% |
| 2020 | $2.5B | +5.5% |
| 2019 | $2.4B | +12.7% |
| 2018 | $2.1B | +8.9% |
| 2017 | $1.9B | −0.7% |
| 2016 | $1.9B | −7.9% |
| 2015 | $2.1B | −5.3% |
| 2014 | $2.2B | +30.4% |
| 2013 | $1.7B | +34.0% |
| 2012 | $1.3B | +21.0% |
| 2011 | $1.1B | +2.4% |
| 2010 | $1.0B | +13.2% |
| 2009 | $911M | −1.5% |
| 2008 | $925M | +19.2% |
| 2007 | $776M | — |